lovastatin has been researched along with Cirrhoses, Experimental Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosch, J; García-Cardeña, G; García-Pagán, JC; Gracia-Sancho, J; Hide, D; Marrone, G; Rosado, E; Russo, L | 1 |
| Calès, P; Feldmann, G; Gallois, Y; Girault, A; le Bouil, A; Le Jeune, JJ; Maïga, MY; Moreau, A; Oberti, F; Pilette, C; Rifflet, H; Saumet, JL | 1 |
2 other study(ies) available for lovastatin and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins.
Topics: Animals; Atorvastatin; Cell Communication; Disease Models, Animal; Endothelial Cells; Gene Expression; Hepatic Stellate Cells; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Portal; Kruppel-Like Transcription Factors; Liver; Liver Circulation; Liver Cirrhosis, Experimental; Lovastatin; Male; Paracrine Communication; Pyrroles; Rats; Rats, Wistar; Simvastatin; Stress, Mechanical | 2013 |
Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation.
Topics: Animals; Bile Ducts; Blood Pressure; Double-Blind Method; Hemodynamics; Hypertension, Portal; Hypolipidemic Agents; Liver; Liver Circulation; Liver Cirrhosis, Experimental; Lovastatin; Male; Pentoxifylline; Portal Vein; Portasystemic Shunt, Surgical; Rats; Rats, Sprague-Dawley; Reference Values; Renal Circulation; Simvastatin; Spironolactone; Vascular Resistance | 1997 |